Valsartan 160mg + Hydrochlorothiazide 12.5mg Tab. (Filrm coated)

Valsartan 160mg + Hydrochlorothiazide 12.5mg Tab. (Filrm coated) is a tablet formulated with Valsartan 160mg + Hydrochlorothiazide 12.5mg . (Filrm coated). The listed active ingredient profile is Valsartan; Hydrochlorothiazide, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascular medicines used to lower blood pressure or manage related cardiovascular conditions. The source identifies the dosage form as tablet with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.